Tag: Ceritinib

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Ceritinib

FDA Approves Pfizer Med for Rare Form of Pediatric Non-Hodgkin Lymphoma

Added to Collection on: 2021-01-15 16:07:30

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Protein kinase inhibitors
Tyrosine kinase receptors
Breakthrough therapy
Lung cancer
Anaplastic lymphoma kinase
Crizotinib
Anaplastic large-cell lymphoma
ROS1
Ceritinib

Click the tags to see associated articles and topics

View Article Details
US FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 00:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
U.S. FDA Expands Approval of Pfizer's LORBRENA® as First-Line Treatment for ALK-Positive ...

Added to Collection on: 2021-03-04 14:44:28

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Lung cancer
Lorlatinib
Ceritinib
ALK inhibitor
Anaplastic lymphoma kinase
ROS1
XALKORI
Pfizer Inc.
Alectinib
u.s. food and drug administration

Click the tags to see associated articles and topics

View Article Details
Pfizer's Lorbrena breaks into front-line ALK lung cancer, jostling with Novartis, Roche and Takeda

Added to Collection on: 2021-03-04 15:45:00

Tags for this article:

Chemical compounds
Piperidines
Organic compounds
Chemistry
Protein kinase inhibitors
Breakthrough therapy
Orphan drugs
Lung cancer
Ceritinib
Crizotinib
ALK inhibitor
Anaplastic lymphoma kinase
Pfizer
XALKORI
Lorbrena
PFIZER'S

Click the tags to see associated articles and topics

View Article Details
Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer ...

Added to Collection on: 2021-03-09 06:00:00

Tags for this article:

Chemical compounds
Organic compounds
Piperidines
Chemistry
Lung cancer
Breakthrough therapy
Protein kinase inhibitors
Tyrosine kinase receptors
Anaplastic lymphoma kinase
Ceritinib
Crizotinib
Alectinib
Roche Group

Click the tags to see associated articles and topics

View Article Details
FDA Approves CDx for Lorlatinib in ALK-Positive Non–Small Cell Lung Cancer

Added to Collection on: 2021-03-09 19:07:21

Tags for this article:

Chemical compounds
Organic compounds
Chemistry
Piperidines
Breakthrough therapy
Protein kinase inhibitors
Lung cancer
Orphan drugs
ALK inhibitor
Ceritinib
Anaplastic lymphoma kinase
Lorlatinib
Roche

Click the tags to see associated articles and topics

View Article Details
FDA Approves Roche?s Alecensa as the First Adjuvant Treatment for People with ALK ...

Added to Collection on: 2024-04-19 15:08:37

Tags for this article:

Lung cancer
Piperidines
Tyrosine kinase receptors
Alectinib
Ketones
Nitriles
ALK inhibitor
Anaplastic lymphoma kinase
Non-small-cell lung cancer
Protein kinase inhibitor
ALK positive lung cancer
Ceritinib

Click the tags to see associated articles and topics

View Article Details
Book a Demo